Northside Hospital Research Program

Find Open Clinical Trials

Return to Search

A Phase 1b Open-label Study to Evaluate the Safety and Anti-cancer activity of Loncastuximab Tesirine in Combination with Other Anti-Cancer Therapies in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (LOTIS 7)

Learn more:
http://www.clinicaltrials.gov/ct2/show/NCT04970901
Protocol Number
NSH1329
Phase
I
Management Group
BMT Program
Oncology Group
BMT Oncology Group
Disease Sites
Non-Hodgkin's Lymphoma
Sponsor Protocol
ADCT-402-105
Principal Investigator
Melhem Solh
Scope
National
Participating Institutions
Northside Hospital - Atlanta (BMT)
Return to Search

Want to learn more?

For further information on our clinical trials, please call the Northside Hospital Research Program at (404) 303-3355 or

Email Us

For further information on our clinical trials, please contact the Northside Hospital Research Program at
(404) 303-3355 or

Call Us
Email Us